Special issue: “Synthesis, Analysis and Applications of Cyclodextrins and Their Derivatives”
Molecules (mdpi) invites the submission of original research papers and review articles concerning innovative synthetic pathways for new CD derivatives,
Biodegradable nanofiber membranes for waste water decontamination
Novel biodegradable nanofilter membrane (BCD-PDA@PLA) was developed by electrospinning poly(L-lactic acid) (PLA) nanofibers as the scaffold, which were then surface
CD-containing electrospun filtering media
A recently published book on electrospun filtering media contains a detailed overview on cyclodextrin-containing nanowebs used for water purification and
Global Cyclodextrin Market Research Report 2018
This report gives a market analysis of Cyclodextrins in the following aspects: Demand, Price, Cost, Sales Revenue, Gross, Gross Margin, Market
Curcumin extract stabilized by gamma-CD
Dr. Wolz Zell GmbH (Geisenheim, Germany) sells capsules containing curcumin (15%) and gamma-cyclodextrin as dietary supplement. The molecular encapsulation of
How air fresheners work?
Chemical Engineering News has published the above drawing by Andy Brunning, author of the popular graphics blog Compound Interest, on
Cyclodextrins against asthma?
A recently reported finding of Canadian researchers proved the specific effect of lysophosphatidic acid (LPA, see the structure below) by
Manipulation of cell membrane phospholipids by methylated alpha-CD
Methylated α-CD (MeACD) loaded with exogenous lipids was used to replace the endogenous phospholipids and sphingolipids from cell plasma membrane
Aldeyra Therapeutics Announces Positive Results from Phase 2b Dry Eye Disease Clinical Trial
Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), a biotechnology company devoted to development of next-generation medicines to improve the lives of
Melinta Therapeutics to Give New Presentations on Antibiotics Portfolio and Pipeline at IDWeek™ 2018
Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial infections, delivered eight
FDA Approves KYPROLIS® (carfilzomib) In Combination With Dexamethasone For Patients With Relapsed Or Refractory Multiple Myeloma
Amgen (NASDAQ:AMGN) recently announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA)